Observan una gran reducción en los embarazos de EE. UU. desde 2010
MIÉRCOLES, 12 de abril de 2023 (HealthDay News) — Las tasas de embarazos en Estados Unidos han sufrido un marcado declive durante la última década, muestran nuevos datos del gobierno.La tasa general de embarazos se redujo en un 12 por ciento entre 20…
Learn MoreAppeals Court Keeps Abortion Pill Available, With Restrictions
THURSDAY, April 13, 2023 (HealthDay News) — A federal appeals court on Wednesday said the abortion pill mifepristone could remain available for now. But the court’s judges added some provisions to their ruling: A block on mailing the pill to patients…
Learn MoreFeds to Toughen Rules on Privacy Around Abortion, Contraceptive Services
WEDNESDAY, April 12, 2023 (HealthDay News) — U.S. officials said Wednesday that they plan to strengthen existing privacy rules to prevent the sharing of private legal reproductive health care information for use in investigations and prosecutions aga…
Learn MoreFeds to Toughen Rules on Privacy Around Abortion, Contraceptive Services
WEDNESDAY, April 12, 2023 (HealthDay News) — U.S. officials said Wednesday that they plan to strengthen existing privacy rules to prevent the sharing of private legal reproductive health care information for use in investigations and prosecutions aga…
Learn MoreBig Drop in U.S. Pregnancies Seen Since 2010
WEDNESDAY, April 12, 2023 (HealthDay News) — Pregnancy rates in the United States suffered a steep decline during the last decade, new government data shows.The overall U.S. pregnancy rate fell by 12% between 2010 and 2019, according to figures relea…
Learn MoreJustice Department Appeals Texas Judge’s Ruling on Abortion Pill
TUESDAY, April 11, 2023 (HealthDay News) — The U.S. Justice Department on Monday appealed a Texas court ruling that invalidates the U.S. Food and Drug Administration approval in 2020 of mifepristone, the first of two drugs taken during a medical abor…
Learn MoreJustice Department Appeals Texas Judge’s Ruling on Abortion Pill
TUESDAY, April 11, 2023 (HealthDay News) – The U.S. Justice Department on Monday appealed a Texas court ruling that invalidates the U.S. Food and Drug Administration’s approval in 2020 of mifepristone, the first of two drugs taken during a medical abo…
Learn MoreJudge’s Challenge to Abortion Pill Access Brings Swift Reaction
MONDAY, April 10, 2023 (HealthDay News) — A Texas federal judge has issued a preliminary ruling that invalidates the U.S. Food and Drug Administration approval in 2000 of mifepristone, the first of two drugs most commonly taken during a medical abort…
Learn MoreJudge’s Challenge to Abortion Pill Access Brings Swift Reaction
MONDAY, April 10, 2023 (HealthDay News) — A Texas federal judge has issued a preliminary ruling that invalidates the U.S. Food and Drug Administration approval in 2000 of mifepristone, the first of two drugs most commonly taken during a medical abort…
Learn MorePerimenopausal Women Less Likely to Achieve RA Remission
THURSDAY, April 6, 2023 (HealthDay News) — For women with rheumatoid arthritis (RA), perimenopausal status is associated with reduced remission compared with premenopausal status, and sex hormone use is associated with higher remission, according to …
Learn More